Acne Digital Highlights Hub

This course will provide you with valuable updates in Acne Vulgaris presented at the 28th Annual Masters of Pediatric Dermatology and the 18th Annual South Beach Symposium:

  • Acne Diagnosis and Treatment in Women
  • Therapeutic Advancements in Acne & Rosacea Therapy
  • Latest Developments in Lasers and Light Therapies for Acne
  • Controversies in Oral Therapy for Acne
  • Pediatric Perspective: Video and slide highlights will also be included from the Masters of Pediatric Dermatology conference for learners interested in the pediatric perspective.

Target Audience

This activity is designed for an audience of physicians, nurses and other healthcare professionals.

Learning Objectives

  • Summarize new and emerging therapies for the treatment of acne across the age spectrum
  • Evaluate the efficacy and safety of acne treatments, including the need to appropriately modify therapy and practice antibiotic stewardship
  • Discuss individualized treatment regimens for patients with acne taking into account evidence-based guidelines, latest clinical data, and patient characteristics
Course summary
Available credit: 
  • 1.75 AMA PRA Category 1 Credit™
  • 1.75 ANCC
  • 1.75 Participation
Course opens: 
07/31/2020
Course expires: 
07/31/2021
Acne Diagnosis and Treatment in WomenDiane S. Berson, M.D.
Therapeutic Advancements in Acne & Rosacea TherapyJames Q. Del Rosso, D.O.
Controversies in Oral Therapy for AcneJames Q. Del Rosso, D.O
Acne in Newborn and PreteensJonette E. Keri, M.D., Ph.D.
Novel Acne Treatments- Preteen Through AdulthoodJonette E. Keri, M.D., Ph.D.
Latest Developments in Lasers and Light Therapies for AcneMichael H. Gold, M.D.

 CME/CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare

Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH Inc., Advancing Knowledge in Healthcare and Tarsus Cardio dba South Beach Symposium. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.

AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

Nurses AKH, Inc., Advancing Knowledge in Healthcare is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is awarded 1.75 Contact Hours.

Activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and Tarsus Cardio dba South Beach Symposium.

Commercial Support This activity is supported by an educational grant from Galderma Laboratories, L.P.

FACULTY DISCLOSURE

NAME

RELATIONSHIP

COMPANY

Diane Berson, MD

N/A

Nothing to disclose

James. Q. Del Rosso, DO

Consultant

Almirall, BioPharmX, Celgene, Dermira, Encore, EPI Health, Foamix, Galderma, Genentech, LaRoche Poisay, LEO Pharma, MC2, Menlo, Novan, Pfizer, Regeneron, Sanofi-Genzyme, SkinFix, SolGel, Sonoma, Ortho, UCB

Contracted Research

Almirall, Anaptys Bio, Athenex, BioPharmX, Celgene, Dermira, Foamix, Galderma, Genentech, Incyte, LEO Pharma, Menlo, Novan, Pfizer, Ralexar, Regeneron, SolGel, Ortho

Salary – Spouse

Regeneron - Asthma Division

Speakers Bureau

Almirall, Celgene, Dermira, Encore, EPI Health, Galderma, Genentech, LEO Pharma, Pfizer, Regeneron, Sanofi-Genzyme, Ortho, UCB, Verrica

Michael Gold, MD

Advisory Board

Aclaris Therapeutic, Aerolase, Almirall, BioDerma, Clarisonic, SkinCeuticals, L’Oreal, Croma, Cutanea, Erchonia, Essence Novel, Evolus, Galderma IntraDerm, Johnson & Johnson, Prollenium, Sensus, Senté, Stratpharma, Thermi Aesthetics

Consultant

Aclaris Therapeutic, Aerolase, Alastin, Allergan, Alma Lasers, Almirall, BioFrontera, Brickell Bio Tech, Celgene, Clarisonic, SkinCeuticals, L’Oreal, Croma, Cutanea, DefenAge, Dermira, DUSA Pharmaceuticals/Sun Pharma, EndyMed, Erchonia, Essence Novel, Exeltis, Galderma, IntraDerm, Invasix, Johnson & Johnson, Joylux, Kadmon, Lumenis, Merz, MTF, Novartis, Pierre Fabre, Prollenium, Promius, Revision, Sensus, Senté, Stratpharm, Suneva, Candela, Thermi Aesthetics, Valeant, Viviscal, Zimmer

Research Funding

Aclaris Therapeutic, Alastin, BioFrontera, Brickell Bio Tech, Croma, Cutanea,Dermira, Invasix, Kadmon, Merz, MTF, Prollenium, Revision, Valeant

Jonette Keri, MD, PhD

N/A

Nothing to disclose

Lawrence A. Schachner, MD

Consultant

Biofrontera, Hoth

Contracted Research

Celgene, Pfizer

Speakers Bureau

Celgene, Pfizer, Sanofi/Genzyme, Regeneron

Stock

Top MD

PLANNER DISCLOSURES

Dorothy Caputo, MA, BSN, RN - CE Director of Accreditations

N/A

Nothing to disclose

AKH Planners and Reviewers

N/A

Nothing to disclose

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

Disclosure of Unlabeled Use and Investigational Product This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclosure Declaration It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review. AKH planners and reviewers have no relevant financial relationships to disclose.

Available Credit

  • 1.75 AMA PRA Category 1 Credit™
  • 1.75 ANCC
  • 1.75 Participation
Please login or register to take this course.

Required Hardware/software

A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.